Orchid Pharma freezes at 10% down circuit as promoter begins stake sale ...Middle East

Dhanuka Laboratories, one of the promoter of Orchid Pharma proposed to sell in aggregate up to 3.28 million equity shares, representing 8.04 per cent of the total equity share capital of the Company.

Hence then, the article about orchid pharma freezes at 10 down circuit as promoter begins stake sale was published today ( Thursday 24/06/2021 - 09:15 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Orchid Pharma freezes at 10% down circuit as promoter begins stake sale )

Also on site :

• The ’80s Hair Metal Classic That Became Too Big for MTV
• Karen Carpenter Reportedly Disliked This 1975 Carpenters Hit So Much She Refused to Perform It
• '80s Hard Rock Band Announces Massive 2026 Tour With Iconic Special Guest